Thiogenesis Therapeutics, Corp.

TSXV:TTI Stock Report

Market Cap: CA$30.5m

Thiogenesis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

TSXV:TTI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Feb 24BuyCA$21,869Patrice RiouxIndividual32,200CA$0.82
15 Dec 23BuyCA$37,500Brook G. RigginsIndividual50,000CA$0.75

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TTI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders10,171,06922.4%
General Public35,324,50677.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.


Top Shareholders

Top 4 shareholders own 22.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
Patrice Rioux
6,770,069CA$4.5m0%no data
3.24%
Vincent Stanton
1,476,000CA$988.9k0%no data
2.31%
Brook G. Riggins
1,050,000CA$703.5k0%no data
1.92%
W. Mullally
875,000CA$586.2k0%no data